Validic, which developed an API to retrieve data from medical devices and wearables tracking health and wellness, has added Everyday Health (NYSE: EVDY) and Pfizer (NYSE: PFE) to its list of clients, according to a statement from the company. It made the announcement at the mHealth Summit this week, just outside of Washington, D.C. Everyday […]
A digital health company that developed an API to free data from mobile health apps, wearables and monitoring devices received an award recognizing its accomplishments from Frost & Sullivan. It presented Validic with its best practices award for customer value leadership. Frost & Sullivan Research Analyst Shruthi Parakkal praised the company especially for its potential […]
Help shape the future of healthcare benefits by sharing your insights.
Validic’s first acquisition shows that data aggregators are on the rise. Health IT companies that can pull data from medical devices, wearables and mobile health apps to make remote monitoring easier for medical staff are helping hospitals as they rely more on outpatient services to generate revenue. The acquisition of Infometers not only illustrates the […]
Validic, a health IT company that developed an API to retrieve data from mobile health apps, wearables and medical devices, has been growing its clinical and wellness device company collaborations. The company, which is backed by Mark Cuban and other investors, has been successful in attracting companies to its collaboration pool, which has grown by […]
At a conference in San Diego this month, a keynote speaker asked how many people in the audience were wearing a fitness tracker. About a dozen people raised their hands. “It’s always the healthiest people you know who are wearing a FitBit,” GreatCall CEO David Inns said. “That’s not going to do anything to cut […]
A mobile health company that wants to make it easier for providers and payers to retrieve patient data from wearables, apps and devices has secured new investment. It received a $1.25 million convertible note from SJF Ventures and angels after raising a seed round last year with notable investors like billionaire Mark Cuban. About 40 […]
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.